<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Acta Neuropathol Commun</journal-id>
      <journal-id journal-id-type="iso-abbrev">Acta Neuropathol Commun</journal-id>
      <journal-title-group>
        <journal-title>Acta Neuropathologica Communications</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2051-5960</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25330907</article-id>
      <article-id pub-id-type="pmc">4209081</article-id>
      <article-id pub-id-type="publisher-id">9140</article-id>
      <article-id pub-id-type="doi">10.1186/s40478-014-0140-8</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Oncogenic codon 13 <italic>NRAS</italic> mutation in a primary mesenchymal brain neoplasm and nevus of a child with neurocutaneous melanosis</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Shih</surname>
            <given-names>Francis</given-names>
          </name>
          <address>
            <email>fshih@exchange.hsc.mb.ca</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yip</surname>
            <given-names>Stephen</given-names>
          </name>
          <address>
            <email>Stephen.Yip@vch.ca</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>McDonald</surname>
            <given-names>Patrick J</given-names>
          </name>
          <address>
            <email>PMcDonald@exchange.hsc.mb.ca</email>
          </address>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chudley</surname>
            <given-names>Albert E</given-names>
          </name>
          <address>
            <email>achudley@hsc.mb.ca</email>
          </address>
          <xref ref-type="aff" rid="Aff4"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Del Bigio</surname>
            <given-names>Marc R</given-names>
          </name>
          <address>
            <email>Marc.Delbigio@med.umanitoba.ca</email>
          </address>
          <xref ref-type="aff" rid="Aff5"/>
        </contrib>
        <aff id="Aff1"><label/>Diagnostic Services Manitoba, Winnipeg, MB Canada </aff>
        <aff id="Aff2"><label/>Department of Pathology &amp; Laboratory Medicine, University of British Columbia, Vancouver, BC Canada </aff>
        <aff id="Aff3"><label/>Section of Neurosurgery, University of Manitoba, Winnipeg, MB Canada </aff>
        <aff id="Aff4"><label/>Department of Biochemistry &amp; Medical Genetics, University of Manitoba, Winnipeg, MB Canada </aff>
        <aff id="Aff5"><label/>Department of Pathology, University of Manitoba and Diagnostic Services Manitoba, Room 401 Brodie Centre, R3E 3P5 Winnipeg, MB Canada </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>21</day>
        <month>10</month>
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>21</day>
        <month>10</month>
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2014</year>
      </pub-date>
      <volume>2</volume>
      <elocation-id>140</elocation-id>
      <history>
        <date date-type="received">
          <day>30</day>
          <month>7</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>8</day>
          <month>9</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Shih et al.; licensee BioMed Central Ltd. 2014</copyright-statement>
        <license license-type="open-access">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <p>A 28-month female with a clinical diagnosis of neurocutaneous melanosis and numerous intracranial abnormalities (including a right choroid plexus tumor and left hemimegalencephaly) presented with a rapidly expanding tumor in the left occipital cerebrum. Microscopic examination of the resected specimen revealed a myxoid mesenchymal neoplasm consisting of fusiform cells that were immunoreactive for vimentin, CD34, and P53 but no melanocyte markers. Focused amplicon deep sequencing on DNA extracted from the brain tumor and a cutaneous nevus revealed a heterozygous (c.37G&#x2009;&gt;&#x2009;C; p.G13R) substitution in the <italic>NRAS</italic> gene. DNA sequencing of &#x201C;normal&#x201D; skin and buccal swab showed the identical <italic>NRAS</italic> change albeit at lower allelic frequency. Her parents did not harbor the <italic>NRAS</italic> mutation. The skin lesion, but not the brain tumor, had a <italic>BRAF</italic> mutation (c.1397G&#x2009;&gt;&#x2009;T; p.G466V). A germline single nucleotide polymorphism in <italic>MET</italic> was found in the child and her father (c.3209C&#x2009;&gt;&#x2009;T; p.T1010I). The findings suggest <italic>NRAS</italic> mosaicism that occurred sometime after conception and imply an oncogenic role of the activating <italic>NRAS</italic> mutation in both the brain and skin lesions in this child.</p>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Melanosis</kwd>
        <kwd>Brain tumor</kwd>
        <kwd>Genetic mutation</kwd>
        <kwd>Somatic mosaicism</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s) 2014</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="introduction">
      <title>Background</title>
      <p>Neurocutaneous melanosis (NCMS; Mendelian Inheritance in Man MIM# 249400) is a rare congenital phakomatosis consisting of numerous giant cutaneous nevi along with extensive leptomeningeal melanosis. Approximately 100 cases have been described in the literature [<xref ref-type="bibr" rid="CR1">1</xref>]. The pathogenesis of NCMS likely involves a morphogenetic error in which melanocyte precursors derived from the neural crest migrate abnormally and proliferate locally [<xref ref-type="bibr" rid="CR2">2</xref>,<xref ref-type="bibr" rid="CR3">3</xref>]. Most cases with an identifiable cause have a somatic gain-of-function mutation in codon 61 of the <italic>NRAS</italic> gene (MIM# 164790) located on chromosome 1p13 [<xref ref-type="bibr" rid="CR4">4</xref>-<xref ref-type="bibr" rid="CR7">7</xref>]. Approximately 30% of affected children have melanin deposits detectable in the leptomeninges or brain [<xref ref-type="bibr" rid="CR8">8</xref>] and half have epilepsy [<xref ref-type="bibr" rid="CR9">9</xref>].</p>
      <p>We present a case of a female infant with NCMS who developed an unusual myxoid mesenchymal brain tumor. DNA sequencing showed shared mutations in codon 13 of <italic>NRAS</italic> in the melanocytic nevi and the brain tumor.</p>
    </sec>
    <sec id="Sec2">
      <title>Case report</title>
      <sec id="Sec3">
        <title>Clinical details</title>
        <p>This female child was born to a healthy non-consanguineous couple after an uneventful full-term pregnancy. At birth she had numerous slightly raised, hairy melanocytic lesions on the scalp, neck, upper trunk, upper extremities, and hands; the largest was 4&#x2013;5&#xA0;cm in greatest dimension (Figure&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>). Skin lesions from the neck, scalp, and arm were previously excised and diagnosed as intradermal and compound nevi with congenital features. She had normal height but was macrocephalic (97th percentile head circumference). She had been admitted to hospital numerous times for uncontrolled seizures starting at age 2&#xA0;months. Magnetic resonance (MR) imaging of the brain and spine was performed at 3.5&#xA0;months age. T1 weighted images showed a solitary 2&#xA0;mm focus of increased signal intensity in the right cerebellopontine cistern; this was thought to represent melanin deposition. Cystic lesions, the largest of which was 2.7&#xA0;cm diameter, with signal characteristics the same as cerebrospinal fluid (CSF) were present around the atria of the lateral ventricles in the right cerebellopontine cistern along with small cysts around the bodies of the lateral ventricles. The left cerebral hemisphere was larger than the right, and parietal white matter volume was abnormally small. The combination of giant congenital nevi along with cerebral melanin deposition led to a clinical diagnosis of NCMS [<xref ref-type="bibr" rid="CR10">10</xref>]. A CT scan of the head performed at 4&#xA0;months age during an episode of status epilepticus showed no additional abnormalities. An abdominal sonogram performed the following day showed no abnormalities. Repeat MR imaging showed the presumed melanocytic nodule had increased to 3&#xA0;mm; it was hyperintense on T1, hypointense on T2, and hyperintense on FLAIR. The periventricular cysts had increased in size and quantity. A new lesion in continuity with the choroid plexus was expanding the temporal horn of the right lateral ventricle. MR imaging of the brain at 21&#xA0;months age showed a new left occipital brain tumor that was T2 hyperintense and enhanced strongly following administration of gadolinium-DTPA. It grew from 1.6 &#xD7; 1.5 &#xD7; 1.2&#xA0;cm to 4.0 &#xD7; 3.6 &#xD7; 3.2&#xA0;cm 4&#xA0;months later (Figure&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>). A left occipital craniotomy was performed at 24.5&#xA0;months age. The tumor was not in contact with the meninges. It had a single vascular pedicle. There was an easily identified plane between it and the adjacent brain. The tumor was removed in one piece without complication. MR imaging of the brain 26&#xA0;months after surgery (51&#xA0;months age) showed no recurrence of the tumor; a vague region of non-enhancing T2 signal abnormality in the right medial occipital lobe had expanded slightly.<fig id="Fig1"><label>Figure 1</label><caption><p>
<bold>Photograph of the patient at 14&#xA0;months age showing giant congenital melanocytic nevi on each shoulder and numerous smaller satellite nevi on the neck, scalp, arms, and upper trunk.</bold>
</p></caption><graphic xlink:href="40478_2014_9140_Fig1_HTML" id="MO1"/></fig><fig id="Fig2"><label>Figure 2</label><caption><p>
<bold>Magnetic resonance image of the brain.</bold> At 14&#xA0;months age (upper image, coronal, T2 weighted) an enlarged left temporal lobe and a tumor of the right choroid plexus (arrow) were apparent. At 23&#xA0;months age (lower image, horizontal, T1-weighted) a 4&#xA0;cm tumor is present in the left occipital lobe. Periventricular cysts are located adjacent to the right occipital horn (arrow).</p></caption><graphic xlink:href="40478_2014_9140_Fig2_HTML" id="MO2"/></fig></p>
      </sec>
      <sec id="Sec4">
        <title>Histopathological characterization</title>
        <p>The tumor was a 4.5 &#xD7; 3.5 &#xD7; 3&#xA0;cm firm tan nodule with a smooth external surface and uniform cut surface (Figure&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>A). The brain tumor and skin biopsies were fixed in 10% neutral buffered formalin, dehydrated and embedded in paraffin wax for sectioning (5 uM in thickness). All samples were stained with hematoxylin and eosin for histologic evaluation. Immunohistochemistry was performed using primary antibodies against vimentin (mouse monoclonal, V9, Dako), CD34 (mouse monoclonal, QBEND-10, Dako), alpha B crystallin (mouse monoclonal, G2JF, Novocastra), CD56 (mouse monoclonal, CD564, Dako), D240 (mouse monoclonal, D2-40, Dako), CD99 (mouse monoclonal, 12E71, Dako), Bcl2 (mouse monoclonal, 124, Dako), p53 (mouse monoclonal, D0-7, Dako), Ki67 (mouse monoclonal, MIB-1, Dako), HLA-DR (mouse monoclonal, CR3/43, Dako), Factor 13a (mouse monoclonal, EP3372, Cellmarque), GFAP (rabbit polyclonal, Dako), S100 (rabbit polyclonal, Dako), Collagen IV (mouse monoclonal, C1V22, Dako), pan-cytokeratin (mouse monoclonal, AE1/AE3, Dako), EMA (mouse monoclonal, E29, Dako), CD57 (mouse monoclonal, TB01, Dako), HMB-45 (mouse monoclonal, HMB45, Dako), MART-1/Melan-A (mouse monoclonal, A103, Dako), calretinin (rabbit polyclonal, Cellmarque), neurofilament (mouse monoclonal, 2&#xA0;F11, Dako), synaptophysin (mouse monoclonal, 27G12, Novocastra), NeuN (mouse monoclonal, A60, Lifespan Biosciences). Antigen retrieval was performed in a Bull&#x2019;s Eye Decloaking chamber (Biocare Medical, Concord, CA) for 1&#xA0;minute at 125&#xB0;C utilizing a Dako pH9 retrieval solution. All antibodies were detected using the Dako Envision system (Dako) and diaminobenzidine precipitation solution. A sample of the tumor was fixed in 2.5% buffered glutaraldehyde, post-fixed in osmium tetroxide, dehydrated in graded ethanol, and embedded in epoxy resin. Semithin sections (0.5&#xA0;&#x3BC;m) were stained with toluidine blue, and ultrathin sections were contrasted with uranyl acetate and lead citrate then viewed with electron microscopy using a JEM 1010 transmission electron microscope (JEOL Ltd., Tokyo, Japan).<fig id="Fig3"><label>Figure 3</label><caption><p>
<bold>Macroscopic and microscopic appearance of the tumor. (A)</bold> The firm tumor was easily dissected from the surrounding brain tissue and had a smooth tan-yellow glistening cut surface. <bold>(B)</bold> Microscopic examination revealed a paucicellular tumor consisting of predominantly fusiform cells in a myxoid background. There is moderate nuclear pleomorphism with a multinucleated cell in the center (hematoxylin &amp; eosin). <bold>(C)</bold> The loose myxoid background stained positive for Alcian blue. <bold>(D)</bold> Immunohistochemical staining for CD34 is diffusely positive. <bold>(E)</bold> Electron microscopic examination showed stellate cells with long delicate processes and occasional multinucleation. <bold>(F)</bold> The extracellular material is abundant with clusters of collagen fibers. (Original magnifications: B-C, &#xD7;400; D, &#xD7;200; E, &#xD7;2000; F &#xD7;30000).</p></caption><graphic xlink:href="40478_2014_9140_Fig3_HTML" id="MO3"/></fig></p>
        <p>Microscopic examination showed an indistinct interface with the brain parenchyma. The tumor had a diffuse pattern of stellate and elongated cells with delicate processes in a loose myxoid background. There were no pigmented cells. Numerous small, multinucleated cells were evenly distributed within the lesion (Figure&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>B). Rarely the cells clustered around blood vessels. Very rare mitotic figures were present and there was no necrosis or endothelial hyperplasia. Focal areas of the extracellular material stained with Alcian blue (Figure&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>C). Reticulin staining was negligible. By immunohistochemistry, the cells were positive for vimentin, CD34 (Figure&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>D), CD56, D240, Bcl2, CD99 (weak), and P53. A subpopulation of cells was Factor 13a positive. An estimated 5-10% of nuclei were Ki67 positive. Only perivascular cells (likely astrocytes) were positive for glial fibrillary acidic protein (GFAP), S100, and alpha B crystallin. Blood vessel walls were positive for E cadherin and collagen IV. There was no immunoreactivity for cytokeratin (AE1/3), epithelial membrane antigen (EMA), CD57, HMB-45, MART-1/Melan-A, calretinin, neurofilament, synaptophysin, or NeuN. Scattered HLA-DR positive cells were likely infiltrating microglia. Electron microscopic examination showed fusiform cells with abundant rough endoplasmic reticulum and prominent intermediate filaments but no specific secretory organelles or obvious intercellular junctions. The cells lacked a well-defined basement membrane and were surrounded by a flocculent extracellular material with rare clusters of striated collagen bundles (Figure&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>E, <xref rid="Fig3" ref-type="fig">3</xref>F). The diagnostic categorization arrived at locally and supported by external consultation was myxoid mesenchymal brain tumor of uncertain growth potential.</p>
      </sec>
      <sec id="Sec5">
        <title>DNA extraction and sequencing</title>
        <p>Genomic DNA was extracted from formalin-fixed paraffin-embedded samples of the intracranial tumor, an excised cutaneous nevus lesion, and grossly unaffected skin. DNA was also extracted from swabbed buccal cells of the patient and both of her parents. DNA was quantitated using the Qubit 2.0 fluorometer (Life Technology). Focused deep sequencing of 10&#xA0;ng of genomic DNA extracted from the above samples was performed using the Ion AmpliSeq Cancer panel (Life Technology). This includes PCR primers covering 739 potential cancer-related hotspot mutations in 46 genes including <italic>KRAS, NRAS, BRAF, PIK3CA, and IDH1</italic> [<xref ref-type="bibr" rid="CR11">11</xref>]. This technology permits the interrogation of genetic alterations including mutations and insertions/deletions, even minor alleles in complex samples, in suboptimal specimens including formalin-fixed paraffin-embedded tissues. Processing of all samples was performed according to the manufacturer&#x2019;s protocol. Construction and enrichment of the emulsion PCR library was performed using the Ion OneTouch instrument. Sequencing was done on Ion 314 and Ion 316 sequencing chips using the Ion Torrent Personal Genome Machine (Life Technology) following the manufacturer&#x2019;s protocol. Data analysis including alignment to hg19 human reference genome, base calling, and identification of variants was done using the Ion Variant Caller (version 2.2). Somatic variants from the brain tumor and the melanocytic nevus were identified after filtering out germline changes identified from the patient&#x2019;s buccal swab. Allele frequency of a variant is calculated by dividing the number of variant reads by total reads in the same nucleotide position. All variants are covered by a minimum of 500 reads.</p>
        <p>The panel identified a missense mutation (chr1:115258745; c.37G&#x2009;&gt;&#x2009;C) in <italic>NRAS</italic> that results in a p. G13R amino acid substitution. The allelic frequency of the nucleotide change in the brain tumor and the cutaneous nevus (58% and 33% respectively) is consistent with a heterozygous mutation (Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>). The same change was observed at an allelic frequency of 4.8% in the normal skin and 2.7% in the buccal swab of the patient. Deep sequencing of DNA extracted from the buccal swabs from both parents did not reveal <italic>NRAS</italic> mutations. A <italic>BRAF</italic> somatic nucleotide change (chr7: 140481441; c.1397G&#x2009;&gt;&#x2009;T) resulting in amino acid substitution p. G466V was detected only in the nevus at an allelic frequency of 32%. A single nucleotide polymorphism (SNP) resulting in a missense mutation (chr7: 116411990; c. 3209C&#x2009;&gt;&#x2009;T; p.T1010I;) was found in the <italic>MET</italic> gene of the child&#x2019;s tumor and buccal swab as well as in the buccal swab of the father.<table-wrap id="Tab1"><label>Table 1</label><caption><p>
<bold>Allelic frequency of nucleotide change in</bold>
<bold><italic>NRAS</italic></bold>
<bold>and</bold>
<bold><italic>BRAF</italic></bold>
<bold>from deep amplicon sequencing of pathology specimens and buccal swabs</bold>
</p></caption><table frame="hsides" rules="groups"><thead><tr valign="top"><th>
<bold>Gene</bold>
</th><th>
<bold>NRAS</bold>
</th><th>
<bold>BRAF</bold>
</th></tr></thead><tbody><tr valign="top"><td>Chromosome position (hg19)</td><td>1:115258745</td><td>7:140481411</td></tr><tr valign="top"><td>Nucleotide change</td><td>c.37G&#x2009;&gt;&#x2009;C</td><td>c.1397G&#x2009;&gt;&#x2009;T</td></tr><tr valign="top"><td>Amino acid change</td><td>p. Gly13Arg</td><td>p. Gly466Val</td></tr><tr valign="top"><td/><td colspan="2">Allelic frequencies (%)</td></tr><tr valign="top"><td>Mesenchymal brain tumor</td><td>58.0</td><td>0.0</td></tr><tr valign="top"><td>Melanocytic nevus</td><td>33.0</td><td>32.0</td></tr><tr valign="top"><td>Normal skin</td><td>4.8</td><td>0.0</td></tr><tr valign="top"><td>Buccal swab</td><td>2.7</td><td>0.0</td></tr><tr valign="top"><td>Mother buccal swab</td><td>0.0</td><td>0.0</td></tr><tr valign="top"><td>Father buccal swab</td><td>0.0</td><td>0.0</td></tr></tbody></table></table-wrap></p>
      </sec>
    </sec>
    <sec id="Sec6" sec-type="conclusion">
      <title>Discussion and conclusions</title>
      <p>Neurocutaneous melanosis (NCMS), first described by Rokitansky in 1861 [<xref ref-type="bibr" rid="CR12">12</xref>], is a rare congenital disorder consisting of multiple large melanocytic cutaneous nevi and melanocytic proliferations in the leptomeninges [<xref ref-type="bibr" rid="CR13">13</xref>]. Malformative lesions of the posterior fossa have rarely been described [<xref ref-type="bibr" rid="CR14">14</xref>,<xref ref-type="bibr" rid="CR15">15</xref>]. Recent genetic findings have clarified the pathogenesis of NCMS and large/giant congenital melanocytic nevi [<xref ref-type="bibr" rid="CR7">7</xref>,<xref ref-type="bibr" rid="CR16">16</xref>]. Single postzygotic mutations of <italic>NRAS</italic> codon 61 and associated mosaicism are responsible for the majority of NCMS cases [<xref ref-type="bibr" rid="CR5">5</xref>] and large/giant congenital melanocytic nevi [<xref ref-type="bibr" rid="CR17">17</xref>]. The same mutation is common in congenital melanocytic nevi [<xref ref-type="bibr" rid="CR18">18</xref>]. The <italic>NRAS</italic> p.G13R somatic mosaicism in this patient is unusual and, to our knowledge, is the first instance reported in association with NCMS. The presence mosaicism in combination with the absence of mutation in the parents suggests this mutation likely occurred after conception. This is consistent with the mosaicism hypotheses for NCMS and other phakomatoses [<xref ref-type="bibr" rid="CR19">19</xref>]. This child does not show any dysmorphic features associated with germline mutations in <italic>NRAS</italic>, which are usually similar to Noonan syndrome [<xref ref-type="bibr" rid="CR20">20</xref>]. <italic>NRAS</italic> mutations are considered important in the genesis of melanoma. NRAS activates four major signaling pathways including RAF-MEK-ERK, RalGDS, PI3K-AKT/PDK1, and PLC/PKC [<xref ref-type="bibr" rid="CR21">21</xref>]. Mutations affecting codons 12, 13 and 61, lead to constitutive activation of RAS GTPase in the absence of growth factor signaling and ultimately neoplastic growth. The specific NRAS G13R mutation identified in this case has been rarely found in melanomas of the skin [<xref ref-type="bibr" rid="CR22">22</xref>-<xref ref-type="bibr" rid="CR24">24</xref>] and esophagus [<xref ref-type="bibr" rid="CR25">25</xref>] as well as in 1/27 patients with large congenital melanocytic nevi [<xref ref-type="bibr" rid="CR26">26</xref>,<xref ref-type="bibr" rid="CR27">27</xref>]. In melanoma the most common <italic>NRAS</italic> (Q61R, Q61L, Q61K) and <italic>BRAF</italic> (V600E, V600K) mutation sites and substitutions differ from those found in this patient [<xref ref-type="bibr" rid="CR28">28</xref>].</p>
      <p>In addition to NCMS, this child had a low-grade mesenchymal brain tumor, which itself is very rare. Typically children with NCMS do not develop sarcomas, although one rhabdomyosarcoma was described in a congenital giant nevus [<xref ref-type="bibr" rid="CR29">29</xref>]. Children with NCMS are reported to develop choroid plexus papilloma and meningioma [<xref ref-type="bibr" rid="CR5">5</xref>]. Primary sarcomas of the brain represented only 0.36% of brain tumors in one very large series [<xref ref-type="bibr" rid="CR30">30</xref>] and 0.7% of all sarcomas in another series [<xref ref-type="bibr" rid="CR31">31</xref>]. Most likely arise from the meninges or blood vessels; among them are rhabdomyosarcoma, fibrosarcoma, leiomyosarcoma, and angiosarcoma. Primary non-meningeal myxoid mesenchymal intracranial tumors are especially rare. Reported cases include two low-grade fibromyxoid sarcomas [<xref ref-type="bibr" rid="CR32">32</xref>,<xref ref-type="bibr" rid="CR33">33</xref>] and one myxofibrosarcoma, the diagnosis of which was based on fluorescent in situ hybridization (FISH) analysis of the <italic>FUS/CREB3L2</italic> translocation [<xref ref-type="bibr" rid="CR34">34</xref>]. Both of these tumors have some features similar to the reported child&#x2019;s brain tumor. It is important to emphasize that the tumor had no morphologic or immunophenotypic features of melanoma. The relatively low-grade appearance of the brain tumor presented herein is discrepant with its rapid growth. The rapid increase in size could be explained by expansion of the myxoid extracellular material rather than neoplastic cell proliferation.</p>
      <p>The heterozygous state of <italic>NRAS</italic> in the melanocytic nevus and the brain tumor combined with additional novel somatic mutations suggest cooperative involvement of oncogenic pathways in the brain tumor and especially in the skin lesions (<italic>BRAF</italic> p.G466V). Only a single sarcoma (a rhabdomyosarcoma) has been described with the <italic>NRAS</italic> p.G13R mutation [<xref ref-type="bibr" rid="CR35">35</xref>]. Somatic mosaics of <italic>NRAS</italic> mutations in almost identical protein regions (G12D, G12S, G13D) have been described in relation to juvenile myelomonocytic leukemia [<xref ref-type="bibr" rid="CR36">36</xref>,<xref ref-type="bibr" rid="CR37">37</xref>]. Note that neurofibromin is a major regulator of the NRAS pathway [<xref ref-type="bibr" rid="CR38">38</xref>]. <italic>NF1</italic> is not assessed in the AmpliSeq Cancer Panel and we did not attempt direct sequencing. However, given that the documented abnormalities are distal to neurofibromin signaling, a mutation in NF1 is not necessary to explain this child&#x2019;s phenotype.</p>
      <p>A germline SNP was found in the <italic>MET</italic> gene of this child (inherited from her father who is not known to have any neoplastic disease). The <italic>MET</italic> gene encodes the receptor for hepatic growth factor/scatter factor (HGF/SF) and appears to be involved in cell motility, proliferation, and invasiveness [<xref ref-type="bibr" rid="CR39">39</xref>]. Mice that overexpress HGF/SF overstimulate the MET pathway and develop melanosis in the central nervous system and patterned hyperpigmentation of the skin similar to NCMS [<xref ref-type="bibr" rid="CR40">40</xref>]. These mice also develop fibrosarcoma and rhabdomyosarcoma [<xref ref-type="bibr" rid="CR41">41</xref>]. MET has been detected by immunohistochemistry in optic canal nevus cells from a child with NCMS [<xref ref-type="bibr" rid="CR42">42</xref>]. The p.T1010I variant has been identified in thyroid carcinomas [<xref ref-type="bibr" rid="CR33">33</xref>], neuroendocrine carcinoma (NEC) of lung [<xref ref-type="bibr" rid="CR43">43</xref>], a pleomorphic xanthoastrocytoma case [<xref ref-type="bibr" rid="CR11">11</xref>], and has been implicated as a risk factor for familial colorectal cancer [<xref ref-type="bibr" rid="CR44">44</xref>]. One early report described this change in MET as capable of altering signaling in NEC [<xref ref-type="bibr" rid="CR45">45</xref>], however more recently this variation was not shown to alter c-Met phosphorylation in NEC [<xref ref-type="bibr" rid="CR46">46</xref>], nor does it seem capable of transforming the Ba/F3 pro-B lymphocyte cell line [<xref ref-type="bibr" rid="CR47">47</xref>]. To summarize, the significance of the <italic>MET</italic> SNP in this child is unclear.</p>
      <p>Hemimegalencephaly has been associated with other neurocutaneous syndromes including epidermal nevus syndrome, proteus syndrome, hypomelanosis of Ito, and neurofibromatosis-1 [<xref ref-type="bibr" rid="CR48">48</xref>,<xref ref-type="bibr" rid="CR49">49</xref>]. Recently, de novo somatic mutations with mosaicism in the PI3K-AKT3-mTOR pathway were shown to cause hemimegalencephaly [<xref ref-type="bibr" rid="CR50">50</xref>]. NRAS is known to have direct interaction with PI3K [<xref ref-type="bibr" rid="CR21">21</xref>]. Given that this child had no mutation in <italic>PI3K</italic>, the <italic>NRAS</italic> mosaicism is likely the explanation for the hemimegalencephaly.</p>
    </sec>
    <sec id="Sec7">
      <title>Conclusion</title>
      <p>In summary, development of a primary intracerebral mesenchymal neoplasm in a child with NCMS and hemimegalencephaly can likely be explained by specific <italic>NRAS</italic> mutant mosaicism possibly in combination with a <italic>MET</italic> germline variation, which together constitute a unique combination. This case highlights the importance of DNA analysis from multiple sites, as well as from parents, in individuals with complex disease states. The presence of an <italic>NRAS</italic> somatic mosaic supports the hypothesized developmental pathogenesis of NCMS. Further exploration of the role of <italic>NRAS</italic> and <italic>MET</italic> in development of the neural crest derived pigment cells will be of interest.</p>
    </sec>
    <sec id="Sec8">
      <title>Consent</title>
      <p>Parents provided explicit consent for genetic tests and use of photographs.</p>
    </sec>
  </body>
  <back>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term>BRAF</term>
          <def>
            <p>B-Raf proto-oncogene, serine/threonine kinase</p>
          </def>
        </def-item>
        <def-item>
          <term>DNA</term>
          <def>
            <p>Deoxyribonucleic acid</p>
          </def>
        </def-item>
        <def-item>
          <term>FISH</term>
          <def>
            <p>Fluorescent in situ hybridization</p>
          </def>
        </def-item>
        <def-item>
          <term>MET</term>
          <def>
            <p>MET proto-oncogene, receptor tyrosine kinase</p>
          </def>
        </def-item>
        <def-item>
          <term>MR</term>
          <def>
            <p>Magnetic resonance</p>
          </def>
        </def-item>
        <def-item>
          <term>NCMS</term>
          <def>
            <p>Neurocutaneous melanosis</p>
          </def>
        </def-item>
        <def-item>
          <term>NRAS</term>
          <def>
            <p>Neuroblastoma RAS viral (v-ras) oncogene homolog</p>
          </def>
        </def-item>
        <def-item>
          <term>PCR</term>
          <def>
            <p>Polymerase chain reaction</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <fn-group>
      <fn>
        <p>
          <bold>Competing interests</bold>
        </p>
        <p>The authors declare that they have no competing interests.</p>
      </fn>
      <fn>
        <p>
          <bold>Authors&#x2019; contributions</bold>
        </p>
        <p>FS &#x2013; Literature review and initial drafts of manuscript. SY &#x2013; Genetic analysis and drafting manuscript. PJM &#x2013; Neurosurgical care of child, editing manuscript. AEC &#x2013; Clinical care of child, genetic explanation, editing manuscript. MRD &#x2013; Conceived project, final synthesis of manuscript. All authors read and approved the final manuscript.</p>
      </fn>
    </fn-group>
    <ack>
      <title>Acknowledgements</title>
      <p>Dr. Del Bigio holds the Canada Research Chair in Developmental Neuropathology. We thank Dr. Peter Burger (Johns Hopkins University) for his consultation on the brain tumor. We thank Tiana Baskin, Sharon Allen and Susan Janeczko for their technical assistance. We are grateful to the family for their cooperation with these investigations and permission to publish the findings. SY would like to acknowledge the funding support of BrainCare BC.</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pavlidou</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Hagel</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Papavasilliou</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Giouroukos</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Panteliadis</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Neurocutaneous melanosis: report of three cases and up-to-date review</article-title>
          <source>J Child Neurol</source>
          <year>2008</year>
          <volume>23</volume>
          <fpage>1382</fpage>
          <lpage>1391</lpage>
          <pub-id pub-id-type="pmid">19073843</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Makkar</surname>
              <given-names>HS</given-names>
            </name>
            <name>
              <surname>Frieden</surname>
              <given-names>IJ</given-names>
            </name>
          </person-group>
          <article-title>Neurocutaneous melanosis</article-title>
          <source>Semin Cutan Med Surg</source>
          <year>2004</year>
          <volume>23</volume>
          <fpage>138</fpage>
          <lpage>144</lpage>
          <pub-id pub-id-type="doi">10.1016/j.sder.2004.01.007</pub-id>
          <pub-id pub-id-type="pmid">15295923</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kinsler</surname>
              <given-names>VA</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Latimer</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Natarajan</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Healy</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Moore</surname>
              <given-names>GE</given-names>
            </name>
            <name>
              <surname>Sebire</surname>
              <given-names>NJ</given-names>
            </name>
          </person-group>
          <article-title>Immunohistochemical and ultrastructural features of congenital melanocytic naevus cells support a stem-cell phenotype</article-title>
          <source>Br J Dermatol</source>
          <year>2013</year>
          <volume>169</volume>
          <fpage>374</fpage>
          <lpage>383</lpage>
          <pub-id pub-id-type="doi">10.1111/bjd.12323</pub-id>
          <pub-id pub-id-type="pmid">23517330</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <collab>Online Mendelian Inheritance in Man</collab>
          </person-group>
          <source>Melanosis, Neurocutaneous; NCMS; MIM#249400</source>
          <year>2014</year>
          <publisher-loc>Baltimore, MD</publisher-loc>
          <publisher-name>Johns Hopkins University</publisher-name>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kinsler</surname>
              <given-names>VA</given-names>
            </name>
            <name>
              <surname>Thomas</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Ishida</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bulstrode</surname>
              <given-names>NW</given-names>
            </name>
            <name>
              <surname>Loughlin</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hing</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Chalker</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>McKenzie</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Abu-Amero</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Slater</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Chanudet</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Palmer</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Morrogh</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Stanier</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Healy</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Sebire</surname>
              <given-names>NJ</given-names>
            </name>
            <name>
              <surname>Moore</surname>
              <given-names>GE</given-names>
            </name>
          </person-group>
          <article-title>Multiple congenital melanocytic nevi and neurocutaneous melanosis are caused by postzygotic mutations in codon 61 of NRAS</article-title>
          <source>J Invest Dermatol</source>
          <year>2013</year>
          <volume>133</volume>
          <fpage>2229</fpage>
          <lpage>2236</lpage>
          <pub-id pub-id-type="doi">10.1038/jid.2013.70</pub-id>
          <pub-id pub-id-type="pmid">23392294</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kusters-Vandevelde</surname>
              <given-names>HV</given-names>
            </name>
            <name>
              <surname>Willemsen</surname>
              <given-names>AE</given-names>
            </name>
            <name>
              <surname>Groenen</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Kusters</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Lammens</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wesseling</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Djafarihamedani</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Rijntjes</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Delye</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Willemsen</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>van Herpen</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Blokx</surname>
              <given-names>WA</given-names>
            </name>
          </person-group>
          <article-title>Experimental treatment of NRAS-mutated neurocutaneous melanocytosis with MEK162, a MEK-inhibitor</article-title>
          <source>Acta Neuropathol Commun</source>
          <year>2014</year>
          <volume>2</volume>
          <fpage>41</fpage>
          <pub-id pub-id-type="doi">10.1186/2051-5960-2-41</pub-id>
          <pub-id pub-id-type="pmid">24713450</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Etchevers</surname>
              <given-names>HC</given-names>
            </name>
          </person-group>
          <article-title>Hiding in plain sight: molecular genetics applied to giant congenital melanocytic nevi</article-title>
          <source>J Invest Dermatol</source>
          <year>2014</year>
          <volume>134</volume>
          <fpage>879</fpage>
          <lpage>882</lpage>
          <pub-id pub-id-type="doi">10.1038/jid.2013.531</pub-id>
          <pub-id pub-id-type="pmid">24646799</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bekiesinska-Figatowska</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Szczygielski</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Boczar</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Madzik</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Klepacka</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Michalak</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Romaniuk-Doroszewska</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Uliasz</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Peczkowski</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Sawicka</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Neurocutaneous melanosis in children with giant congenital melanocytic nevi</article-title>
          <source>Clin Imaging</source>
          <year>2014</year>
          <volume>38</volume>
          <fpage>79</fpage>
          <lpage>84</lpage>
          <pub-id pub-id-type="doi">10.1016/j.clinimag.2013.10.001</pub-id>
          <pub-id pub-id-type="pmid">24239041</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ramaswamy</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Delaney</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Haque</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Marghoob</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Khakoo</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Spectrum of central nervous system abnormalities in neurocutaneous melanocytosis</article-title>
          <source>Dev Med Child Neurol</source>
          <year>2012</year>
          <volume>54</volume>
          <fpage>563</fpage>
          <lpage>568</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1469-8749.2012.04275.x</pub-id>
          <pub-id pub-id-type="pmid">22469364</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Scattolin</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Peruchi</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Rocha</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Masruha</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Vilanova</surname>
              <given-names>LC</given-names>
            </name>
          </person-group>
          <article-title>Neurocutaneous melanosis: follow-up and literature review</article-title>
          <source>J Neuroradiol</source>
          <year>2011</year>
          <volume>38</volume>
          <fpage>313</fpage>
          <lpage>318</lpage>
          <pub-id pub-id-type="doi">10.1016/j.neurad.2011.02.007</pub-id>
          <pub-id pub-id-type="pmid">21489630</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yang</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Singhal</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Rassekh</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Yip</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Eydoux</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Dunham</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Possible differentiation of cerebral glioblastoma into pleomorphic xanthoastrocytoma: an unusual case in an infant</article-title>
          <source>J Neurosurg Pediatr</source>
          <year>2012</year>
          <volume>9</volume>
          <fpage>517</fpage>
          <lpage>523</lpage>
          <pub-id pub-id-type="doi">10.3171/2012.1.PEDS11326</pub-id>
          <pub-id pub-id-type="pmid">22546030</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rokitansky</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Ein ausgezeichneter Fall von Pigment-mal mit ausgebreiteter Pigmentierung der inneren Hin- und Ruchenmarkshaute</article-title>
          <source>Allg Wien Med Z</source>
          <year>1861</year>
          <volume>6</volume>
          <fpage>113</fpage>
          <lpage>116</lpage>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fu</surname>
              <given-names>YJ</given-names>
            </name>
            <name>
              <surname>Morota</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Nakagawa</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Takahashi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kakita</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Neurocutaneous melanosis: surgical pathological features of an apparently hamartomatous lesion in the amygdala</article-title>
          <source>J Neurosurg Pediatr</source>
          <year>2010</year>
          <volume>6</volume>
          <fpage>82</fpage>
          <lpage>86</lpage>
          <pub-id pub-id-type="doi">10.3171/2010.3.PEDS1025</pub-id>
          <pub-id pub-id-type="pmid">20593992</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>De Cock</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Snauwaert</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Van Rompaey</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Morren</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Demaerel</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>A newborn with neurocutaneous melanocytosis and Dandy-Walker malformation</article-title>
          <source>Pediatr Neurol</source>
          <year>2014</year>
          <volume>50</volume>
          <fpage>276</fpage>
          <lpage>278</lpage>
          <pub-id pub-id-type="doi">10.1016/j.pediatrneurol.2013.04.006</pub-id>
          <pub-id pub-id-type="pmid">24321541</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Frieden</surname>
              <given-names>IJ</given-names>
            </name>
            <name>
              <surname>Williams</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Barkovich</surname>
              <given-names>AJ</given-names>
            </name>
          </person-group>
          <article-title>Giant congenital melanocytic nevi: brain magnetic resonance findings in neurologically asymptomatic children</article-title>
          <source>J Am Acad Dermatol</source>
          <year>1994</year>
          <volume>31</volume>
          <fpage>423</fpage>
          <lpage>429</lpage>
          <pub-id pub-id-type="doi">10.1016/S0190-9622(94)70204-7</pub-id>
          <pub-id pub-id-type="pmid">8077466</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gerami</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Paller</surname>
              <given-names>AS</given-names>
            </name>
          </person-group>
          <article-title>Making a mountain out of a molehill: NRAS, mosaicism, and large congenital nevi</article-title>
          <source>J Invest Dermatol</source>
          <year>2013</year>
          <volume>133</volume>
          <fpage>2127</fpage>
          <lpage>2130</lpage>
          <pub-id pub-id-type="doi">10.1038/jid.2013.146</pub-id>
          <pub-id pub-id-type="pmid">23949765</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Charbel</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Fontaine</surname>
              <given-names>RH</given-names>
            </name>
            <name>
              <surname>Malouf</surname>
              <given-names>GG</given-names>
            </name>
            <name>
              <surname>Picard</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kadlub</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>El-Murr</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>How-Kit</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Su</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Coulomb-L&#x2019;Hermine</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Tost</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Mourah</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Aractingi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Guegan</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>NRAS mutation is the sole recurrent somatic mutation in large congenital melanocytic nevi</article-title>
          <source>J Invest Dermatol</source>
          <year>2014</year>
          <volume>134</volume>
          <fpage>1067</fpage>
          <lpage>1074</lpage>
          <pub-id pub-id-type="doi">10.1038/jid.2013.429</pub-id>
          <pub-id pub-id-type="pmid">24129063</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bauer</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Curtin</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Pinkel</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Bastian</surname>
              <given-names>BC</given-names>
            </name>
          </person-group>
          <article-title>Congenital melanocytic nevi frequently harbor NRAS mutations but no BRAF mutations</article-title>
          <source>J Invest Dermatol</source>
          <year>2007</year>
          <volume>127</volume>
          <fpage>179</fpage>
          <lpage>182</lpage>
          <pub-id pub-id-type="doi">10.1038/sj.jid.5700490</pub-id>
          <pub-id pub-id-type="pmid">16888631</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hamm</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Cutaneous mosaicism of lethal mutations</article-title>
          <source>Am J Med Genet</source>
          <year>1999</year>
          <volume>85</volume>
          <fpage>342</fpage>
          <lpage>345</lpage>
          <pub-id pub-id-type="doi">10.1002/(SICI)1096-8628(19990806)85:4&lt;342::AID-AJMG6&gt;3.0.CO;2-8</pub-id>
          <pub-id pub-id-type="pmid">10398256</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cirstea</surname>
              <given-names>IC</given-names>
            </name>
            <name>
              <surname>Kutsche</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Dvorsky</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Gremer</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Carta</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Horn</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Roberts</surname>
              <given-names>AE</given-names>
            </name>
            <name>
              <surname>Lepri</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Merbitz-Zahradnik</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Konig</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A restricted spectrum of NRAS mutations causes Noonan syndrome</article-title>
          <source>Nat Genet</source>
          <year>2010</year>
          <volume>42</volume>
          <fpage>27</fpage>
          <lpage>29</lpage>
          <pub-id pub-id-type="doi">10.1038/ng.497</pub-id>
          <pub-id pub-id-type="pmid">19966803</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ross</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Sanchez</surname>
              <given-names>MI</given-names>
            </name>
            <name>
              <surname>Grichnik</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>Molecular nevogenesis</article-title>
          <source>Dermatol Res Pract</source>
          <year>2011</year>
          <volume>2011</volume>
          <fpage>463184</fpage>
          <pub-id pub-id-type="pmid">21754924</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ball</surname>
              <given-names>NJ</given-names>
            </name>
            <name>
              <surname>Yohn</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Morelli</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Norris</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Golitz</surname>
              <given-names>LE</given-names>
            </name>
            <name>
              <surname>Hoeffler</surname>
              <given-names>JP</given-names>
            </name>
          </person-group>
          <article-title>Ras mutations in human melanoma: a marker of malignant progression</article-title>
          <source>J Invest Dermatol</source>
          <year>1994</year>
          <volume>102</volume>
          <fpage>285</fpage>
          <lpage>290</lpage>
          <pub-id pub-id-type="doi">10.1111/1523-1747.ep12371783</pub-id>
          <pub-id pub-id-type="pmid">8120410</pub-id>
        </element-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>van Elsas</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Zerp</surname>
              <given-names>SF</given-names>
            </name>
            <name>
              <surname>van der Flier</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kruse</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Aarnoudse</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Hayward</surname>
              <given-names>NK</given-names>
            </name>
            <name>
              <surname>Ruiter</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Schrier</surname>
              <given-names>PI</given-names>
            </name>
          </person-group>
          <article-title>Relevance of ultraviolet-induced N-ras oncogene point mutations in development of primary human cutaneous melanoma</article-title>
          <source>Am J Pathol</source>
          <year>1996</year>
          <volume>149</volume>
          <fpage>883</fpage>
          <lpage>893</lpage>
          <pub-id pub-id-type="pmid">8780392</pub-id>
        </element-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pavey</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Johansson</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Packer</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Taylor</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Stark</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Pollock</surname>
              <given-names>PM</given-names>
            </name>
            <name>
              <surname>Walker</surname>
              <given-names>GJ</given-names>
            </name>
            <name>
              <surname>Boyle</surname>
              <given-names>GM</given-names>
            </name>
            <name>
              <surname>Harper</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Cozzi</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Hansen</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Yudt</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Schmidt</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Hersey</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Ellem</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>O'Rourke</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Parsons</surname>
              <given-names>PG</given-names>
            </name>
            <name>
              <surname>Meltzer</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Ringner</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hayward</surname>
              <given-names>NK</given-names>
            </name>
          </person-group>
          <article-title>Microarray expression profiling in melanoma reveals a BRAF mutation signature</article-title>
          <source>Oncogene</source>
          <year>2004</year>
          <volume>23</volume>
          <fpage>4060</fpage>
          <lpage>4067</lpage>
          <pub-id pub-id-type="doi">10.1038/sj.onc.1207563</pub-id>
          <pub-id pub-id-type="pmid">15048078</pub-id>
        </element-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sekine</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Nakanishi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Ogawa</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Kouda</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kanai</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Esophageal melanomas harbor frequent NRAS mutations unlike melanomas of other mucosal sites</article-title>
          <source>Virchows Arch</source>
          <year>2009</year>
          <volume>454</volume>
          <fpage>513</fpage>
          <lpage>517</lpage>
          <pub-id pub-id-type="doi">10.1007/s00428-009-0762-6</pub-id>
          <pub-id pub-id-type="pmid">19319568</pub-id>
        </element-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dessars</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>De Raeve</surname>
              <given-names>LE</given-names>
            </name>
            <name>
              <surname>Morandini</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Lefort</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>El Housni</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ghanem</surname>
              <given-names>GE</given-names>
            </name>
            <name>
              <surname>Van den Eynde</surname>
              <given-names>BJ</given-names>
            </name>
            <name>
              <surname>Ma</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Roseeuw</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Vassart</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Libert</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Heimann</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Genotypic and gene expression studies in congenital melanocytic nevi: insight into initial steps of melanotumorigenesis</article-title>
          <source>J Invest Dermatol</source>
          <year>2009</year>
          <volume>129</volume>
          <fpage>139</fpage>
          <lpage>147</lpage>
          <pub-id pub-id-type="doi">10.1038/jid.2008.203</pub-id>
          <pub-id pub-id-type="pmid">18633438</pub-id>
        </element-citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Phadke</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Rakheja</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Le</surname>
              <given-names>LP</given-names>
            </name>
            <name>
              <surname>Selim</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Kapur</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Davis</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Mihm</surname>
              <given-names>MC</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Hoang</surname>
              <given-names>MP</given-names>
            </name>
          </person-group>
          <article-title>Proliferative nodules arising within congenital melanocytic nevi: a histologic, immunohistochemical, and molecular analyses of 43 cases</article-title>
          <source>Am J Surg Pathol</source>
          <year>2011</year>
          <volume>35</volume>
          <fpage>656</fpage>
          <lpage>669</lpage>
          <pub-id pub-id-type="doi">10.1097/PAS.0b013e31821375ea</pub-id>
          <pub-id pub-id-type="pmid">21436676</pub-id>
        </element-citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Colombino</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Capone</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lissia</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Cossu</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Rubino</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>De Giorgi</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Massi</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Fonsatti</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Staibano</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Nappi</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Pagani</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Casula</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Manca</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sini</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Franco</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Botti</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Caraco</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Mozzillo</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Ascierto</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Palmieri</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>BRAF/NRAS mutation frequencies among primary tumors and metastases in patients with melanoma</article-title>
          <source>J Clin Oncol</source>
          <year>2012</year>
          <volume>30</volume>
          <fpage>2522</fpage>
          <lpage>2529</lpage>
          <pub-id pub-id-type="doi">10.1200/JCO.2011.41.2452</pub-id>
          <pub-id pub-id-type="pmid">22614978</pub-id>
        </element-citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zuniga</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Las Heras</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Benveniste</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Rhabdomyosarcoma arising in a congenital giant nevus associated with neurocutaneous melanosis in a neonate</article-title>
          <source>J Pediatr Surg</source>
          <year>1987</year>
          <volume>22</volume>
          <fpage>1036</fpage>
          <lpage>1038</lpage>
          <pub-id pub-id-type="doi">10.1016/S0022-3468(87)80513-4</pub-id>
          <pub-id pub-id-type="pmid">3430311</pub-id>
        </element-citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Paulus</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Slowik</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Jellinger</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Primary intracranial sarcomas: histopathological features of 19 cases</article-title>
          <source>Histopathology</source>
          <year>1991</year>
          <volume>18</volume>
          <fpage>395</fpage>
          <lpage>402</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1365-2559.1991.tb00869.x</pub-id>
          <pub-id pub-id-type="pmid">1715839</pub-id>
        </element-citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Toro</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Travis</surname>
              <given-names>LB</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Fletcher</surname>
              <given-names>CD</given-names>
            </name>
            <name>
              <surname>Devesa</surname>
              <given-names>SS</given-names>
            </name>
          </person-group>
          <article-title>Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978&#x2013;2001: An analysis of 26,758 cases</article-title>
          <source>Int J Cancer</source>
          <year>2006</year>
          <volume>119</volume>
          <fpage>2922</fpage>
          <lpage>2930</lpage>
          <pub-id pub-id-type="doi">10.1002/ijc.22239</pub-id>
          <pub-id pub-id-type="pmid">17013893</pub-id>
        </element-citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tun</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ozen</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Kaptanoglu</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Gurcan</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Beskonakli</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Celasun</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Primary intracranial low-grade fibromyxoid sarcoma (Evans tumor)</article-title>
          <source>J Clin Neurosci</source>
          <year>2008</year>
          <volume>15</volume>
          <fpage>1298</fpage>
          <lpage>1301</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jocn.2007.07.085</pub-id>
          <pub-id pub-id-type="pmid">18771926</pub-id>
        </element-citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ricarte-Filho</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Ryder</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Chitale</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Rivera</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Heguy</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ladanyi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Janakiraman</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Solit</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Knauf</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Tuttle</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Ghossein</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Fagin</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1</article-title>
          <source>Cancer Res</source>
          <year>2009</year>
          <volume>69</volume>
          <fpage>4885</fpage>
          <lpage>4893</lpage>
          <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-09-0727</pub-id>
          <pub-id pub-id-type="pmid">19487299</pub-id>
        </element-citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Buccoliero</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Castiglione</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Garbini</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Rossi Degl&#x2019;Innocenti</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Moncini</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Franchi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Paglierani</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Simoni</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Baroni</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Daniele</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Sardi</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Giordano</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Mussa</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Arico</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Genitori</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Taddei</surname>
              <given-names>GL</given-names>
            </name>
          </person-group>
          <article-title>Primary cerebral myxofibrosarcoma: clinical, morphologic, immunohistochemical, molecular, and ultrastructural study of an infrequent tumor in an extraordinary localization</article-title>
          <source>J Pediatr Hematol Oncol</source>
          <year>2011</year>
          <volume>33</volume>
          <fpage>e279</fpage>
          <lpage>e283</lpage>
          <pub-id pub-id-type="pmid">21716137</pub-id>
        </element-citation>
      </ref>
      <ref id="CR35">
        <label>35.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stratton</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Fisher</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Gusterson</surname>
              <given-names>BA</given-names>
            </name>
            <name>
              <surname>Cooper</surname>
              <given-names>CS</given-names>
            </name>
          </person-group>
          <article-title>Detection of point mutations in N-ras and K-ras genes of human embryonal rhabdomyosarcomas using oligonucleotide probes and the polymerase chain reaction</article-title>
          <source>Cancer Res</source>
          <year>1989</year>
          <volume>49</volume>
          <fpage>6324</fpage>
          <lpage>6327</lpage>
          <pub-id pub-id-type="pmid">2680062</pub-id>
        </element-citation>
      </ref>
      <ref id="CR36">
        <label>36.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Doisaki</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Muramatsu</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Shimada</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Takahashi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Mori-Ezaki</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sato</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kawaguchi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kinoshita</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sotomatsu</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hayashi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Furukawa-Hibi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Yamada</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Hoshino</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kiyoi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Yoshida</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Sakaguchi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Narita</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Ismael</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Nishio</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Tanaka</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hama</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Koike</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kojima</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Somatic mosaicism for oncogenic NRAS mutations in juvenile myelomonocytic leukemia</article-title>
          <source>Blood</source>
          <year>2012</year>
          <volume>120</volume>
          <fpage>1485</fpage>
          <lpage>1488</lpage>
          <pub-id pub-id-type="doi">10.1182/blood-2012-02-406090</pub-id>
          <pub-id pub-id-type="pmid">22753870</pub-id>
        </element-citation>
      </ref>
      <ref id="CR37">
        <label>37.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>De Filippi</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Zecca</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lisini</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Rosti</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Cagioni</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Carlo-Stella</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Radi</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Veggiotti</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Mastronuzzi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Acquaviva</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>D'Ambrosio</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Locatelli</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Danesino</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Germ-line mutation of the NRAS gene may be responsible for the development of juvenile myelomonocytic leukaemia</article-title>
          <source>Br J Haematol</source>
          <year>2009</year>
          <volume>147</volume>
          <fpage>706</fpage>
          <lpage>709</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1365-2141.2009.07894.x</pub-id>
          <pub-id pub-id-type="pmid">19775298</pub-id>
        </element-citation>
      </ref>
      <ref id="CR38">
        <label>38.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Harrisingh</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Lloyd</surname>
              <given-names>AC</given-names>
            </name>
          </person-group>
          <article-title>Ras/Raf/ERK signalling and NF1</article-title>
          <source>Cell Cycle</source>
          <year>2004</year>
          <volume>3</volume>
          <fpage>1255</fpage>
          <lpage>1258</lpage>
          <pub-id pub-id-type="doi">10.4161/cc.3.10.1182</pub-id>
          <pub-id pub-id-type="pmid">15467460</pub-id>
        </element-citation>
      </ref>
      <ref id="CR39">
        <label>39.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Boccaccio</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Comoglio</surname>
              <given-names>PM</given-names>
            </name>
          </person-group>
          <article-title>Invasive growth: a MET-driven genetic programme for cancer and stem cells</article-title>
          <source>Nat Rev Cancer</source>
          <year>2006</year>
          <volume>6</volume>
          <fpage>637</fpage>
          <lpage>645</lpage>
          <pub-id pub-id-type="doi">10.1038/nrc1912</pub-id>
          <pub-id pub-id-type="pmid">16862193</pub-id>
        </element-citation>
      </ref>
      <ref id="CR40">
        <label>40.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Takayama</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>La Rochelle</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>Anver</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bockman</surname>
              <given-names>DE</given-names>
            </name>
            <name>
              <surname>Merlino</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Scatter factor/hepatocyte growth factor as a regulator of skeletal muscle and neural crest development</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>1996</year>
          <volume>93</volume>
          <fpage>5866</fpage>
          <lpage>5871</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.93.12.5866</pub-id>
          <pub-id pub-id-type="pmid">8650184</pub-id>
        </element-citation>
      </ref>
      <ref id="CR41">
        <label>41.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Takayama</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>LaRochelle</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>Sharp</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Otsuka</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kriebel</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Anver</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Aaronson</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Merlino</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>1997</year>
          <volume>94</volume>
          <fpage>701</fpage>
          <lpage>706</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.94.2.701</pub-id>
          <pub-id pub-id-type="pmid">9012848</pub-id>
        </element-citation>
      </ref>
      <ref id="CR42">
        <label>42.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Takayama</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Nagashima</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Hara</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Takagi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Mori</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Merlino</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Nakazato</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Immunohistochemical detection of the c-met proto-oncogene product in the congenital melanocytic nevus of an infant with neurocutaneous melanosis</article-title>
          <source>J Am Acad Dermatol</source>
          <year>2001</year>
          <volume>44</volume>
          <fpage>538</fpage>
          <lpage>540</lpage>
          <pub-id pub-id-type="doi">10.1067/mjd.2001.112403</pub-id>
          <pub-id pub-id-type="pmid">11209133</pub-id>
        </element-citation>
      </ref>
      <ref id="CR43">
        <label>43.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tengs</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Paez</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>LaFramboise</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Giannoukos</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Thomas</surname>
              <given-names>RK</given-names>
            </name>
          </person-group>
          <article-title>A transforming MET mutation discovered in non-small cell lung cancer using microarray-based resequencing</article-title>
          <source>Cancer Lett</source>
          <year>2006</year>
          <volume>239</volume>
          <fpage>227</fpage>
          <lpage>233</lpage>
          <pub-id pub-id-type="doi">10.1016/j.canlet.2005.08.007</pub-id>
          <pub-id pub-id-type="pmid">16171945</pub-id>
        </element-citation>
      </ref>
      <ref id="CR44">
        <label>44.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Neklason</surname>
              <given-names>DW</given-names>
            </name>
            <name>
              <surname>Done</surname>
              <given-names>MW</given-names>
            </name>
            <name>
              <surname>Sargent</surname>
              <given-names>NR</given-names>
            </name>
            <name>
              <surname>Schwartz</surname>
              <given-names>AG</given-names>
            </name>
            <name>
              <surname>Anton-Culver</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Griffin</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Ahnen</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Schildkraut</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Tomlinson</surname>
              <given-names>GE</given-names>
            </name>
            <name>
              <surname>Strong</surname>
              <given-names>LC</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Stopfer</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Burt</surname>
              <given-names>RW</given-names>
            </name>
          </person-group>
          <article-title>Activating mutation in MET oncogene in familial colorectal cancer</article-title>
          <source>BMC Cancer</source>
          <year>2011</year>
          <volume>11</volume>
          <fpage>424</fpage>
          <pub-id pub-id-type="doi">10.1186/1471-2407-11-424</pub-id>
          <pub-id pub-id-type="pmid">21970370</pub-id>
        </element-citation>
      </ref>
      <ref id="CR45">
        <label>45.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ma</surname>
              <given-names>PC</given-names>
            </name>
            <name>
              <surname>Kijima</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Maulik</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Fox</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Sattler</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Griffin</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>BE</given-names>
            </name>
            <name>
              <surname>Salgia</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions</article-title>
          <source>Cancer Res</source>
          <year>2003</year>
          <volume>63</volume>
          <fpage>6272</fpage>
          <lpage>6281</lpage>
          <pub-id pub-id-type="pmid">14559814</pub-id>
        </element-citation>
      </ref>
      <ref id="CR46">
        <label>46.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Voortman</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Harada</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>RP</given-names>
            </name>
            <name>
              <surname>Killian</surname>
              <given-names>JK</given-names>
            </name>
            <name>
              <surname>Suuriniemi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>WI</given-names>
            </name>
            <name>
              <surname>Meltzer</surname>
              <given-names>PS</given-names>
            </name>
            <name>
              <surname>Lucchi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Giaccone</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Detection and therapeutic implications of c-Met mutations in small cell lung cancer and neuroendocrine tumors</article-title>
          <source>Curr Pharm Des</source>
          <year>2013</year>
          <volume>19</volume>
          <fpage>833</fpage>
          <lpage>840</lpage>
          <pub-id pub-id-type="doi">10.2174/138161213804547196</pub-id>
          <pub-id pub-id-type="pmid">22973954</pub-id>
        </element-citation>
      </ref>
      <ref id="CR47">
        <label>47.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tyner</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Fletcher</surname>
              <given-names>LB</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>EQ</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>WF</given-names>
            </name>
            <name>
              <surname>Rutenberg-Schoenberg</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Beadling</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Mori</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Heinrich</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Deininger</surname>
              <given-names>MW</given-names>
            </name>
            <name>
              <surname>Druker</surname>
              <given-names>BJ</given-names>
            </name>
            <name>
              <surname>Loriaux</surname>
              <given-names>MM</given-names>
            </name>
          </person-group>
          <article-title>MET receptor sequence variants R970C and T992I lack transforming capacity</article-title>
          <source>Cancer Res</source>
          <year>2010</year>
          <volume>70</volume>
          <fpage>6233</fpage>
          <lpage>6237</lpage>
          <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-10-0429</pub-id>
          <pub-id pub-id-type="pmid">20670955</pub-id>
        </element-citation>
      </ref>
      <ref id="CR48">
        <label>48.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Flores-Sarnat</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Hemimegalencephaly: part 1. Genetic, clinical, and imaging aspects</article-title>
          <source>J Child Neurol</source>
          <year>2002</year>
          <volume>17</volume>
          <fpage>373</fpage>
          <lpage>384</lpage>
          <pub-id pub-id-type="doi">10.1177/088307380201700512</pub-id>
          <pub-id pub-id-type="pmid">12150586</pub-id>
        </element-citation>
      </ref>
      <ref id="CR49">
        <label>49.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Flores-Sarnat</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Neurocutaneous melanocytosis</article-title>
          <source>Handb Clin Neurol</source>
          <year>2013</year>
          <volume>111</volume>
          <fpage>369</fpage>
          <lpage>388</lpage>
          <pub-id pub-id-type="doi">10.1016/B978-0-444-52891-9.00042-7</pub-id>
          <pub-id pub-id-type="pmid">23622187</pub-id>
        </element-citation>
      </ref>
      <ref id="CR50">
        <label>50.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Huynh</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Silhavy</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Dixon-Salazar</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Heiberg</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Scott</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Bafna</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Hill</surname>
              <given-names>KJ</given-names>
            </name>
            <name>
              <surname>Collazo</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Funari</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Russ</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Gabriel</surname>
              <given-names>SB</given-names>
            </name>
            <name>
              <surname>Mathern</surname>
              <given-names>GW</given-names>
            </name>
            <name>
              <surname>Gleeson</surname>
              <given-names>JG</given-names>
            </name>
          </person-group>
          <article-title>De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly</article-title>
          <source>Nat Genet</source>
          <year>2012</year>
          <volume>44</volume>
          <fpage>941</fpage>
          <lpage>945</lpage>
          <pub-id pub-id-type="doi">10.1038/ng.2329</pub-id>
          <pub-id pub-id-type="pmid">22729223</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
